HomeThe Column

The Column

Riding the Trend: Staffing Pharma Startups in Japan

Philip Carrigan

Three years ago, almost to the day, we wrote an article boldly titled “Investigating the Myths About Opening a Subsidiary in Japan.” At the time, we felt that several factors were in place indicating that foreign rare-disease and orphan-drug companies should consider setting up their own subsidiaries here. It made, and still makes, no sense for many of these companies to out-license their products to local partners ...


News Calendar